AirSculpt Technologies, Inc.
AIRS Healthcare Medical Care Facilities
AirSculpt Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $151.8 million, down 15.8% from fiscal 2024. In the quarter to June 2026, revenue fell 2.53%, EPS fell 57.0%, free cash flow fell 131.1% and total debt fell 24.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow AIRS
AirSculpt Technologies, Inc. (AIRS) EV/Sales
As of 16 October 2026, AirSculpt Technologies, Inc. (AIRS) trades at a EV/Sales of 0.8×. Over the past ten years it has ranged from 0.8× (October 2026) to 9.3× (December 2021) — the current reading is the lowest in ten years. That is below the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.1× | (45.68%) |
| FY2024 | 2.0× | (15.37%) |
| FY2023 | 2.4× | 44.23% |
| FY2022 | 1.7× | (78.14%) |
| FY2021 | 7.6× | (8.49%) |
| FY2020 | 8.3× | 0.00% |
| FY2019 | 8.3× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 2.3× | 53.90% |
| Mar 2026 | 1.5× | 34.30% |
| Dec 2025 | 1.1× | (68.56%) |
| Sep 2025 | 3.5× | 71.55% |
| 20 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| DCGO DocGo Inc. compare | 0.0× |
| PIII P3 Health Partners Inc. compare | 0.1× |
| PARK Park Dental Partners, Inc. compare | 0.3× |
| AIRS AirSculpt Technologies, Inc. | 0.8× |
| BTMD biote Corp. compare | 0.8× |
| AUNA Auna S.A. compare | 1.0× |
| CCEL Cryo-Cell International Inc. compare | 1.3× |
| JYNT The Joint Corp. compare | 1.4× |
| SRTA Strata Critical Medical, Inc. compare | 1.4× |
| Medical Care Facilities industry median | 1.3× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)